Hollencrest Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$52.4K	Buy	410 +14	+4%	+$1.75K	﹤0.01%	543
2025 Q4	$48.3K	Buy	396 +19	+5%	+$2.18K	﹤0.01%	571
2025 Q3	$37.8K	Buy	377 +17	+5%	+$1.53K	﹤0.01%	599
2025 Q2	$29.9K	Hold	360	–	–	﹤0.01%	599
2025 Q1	$29.2K	Hold	360	–	–	﹤0.01%	601
2024 Q4	$32.4K	Sell	360 -31	-8%	-$3K	﹤0.01%	608
2024 Q3	$38.6K	Sell	391 -17	-4%	-$1.67K	﹤0.01%	555
2024 Q2	$37.8K	Hold	408	–	–	﹤0.01%	562
2024 Q1	$38.7K	Hold	408	–	–	﹤0.01%	523
2023 Q4	$36.4K	Buy	408 +108	+36%	+$8.02K	﹤0.01%	534
2023 Q3	$21.9K	Hold	300	–	–	﹤0.01%	610
2023 Q2	$25K	Hold	300	–	–	﹤0.01%	611
2023 Q1	$22.9K	Hold	300	–	–	﹤0.01%	615
2022 Q4	$24.9K	Buy	+300	New	+$24.3K	﹤0.01%	570
2018 Q3	–	Sell	-2,587	Closed	-$247K	–	354
2018 Q2	$247K	Buy	+2,587	New	+$238K	0.03%	233